Literature DB >> 8892715

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group.

J A Cauley1, F L Lucas, L H Kuller, M T Vogt, W S Browner, S R Cummings.   

Abstract

OBJECTIVE: To test the hypothesis that bone mineral density (BMD) is associated with the risk of developing breast cancer in older women.
DESIGN: Prospective cohort study with mean (SD) follow-up of 3.2 (1.6) years.
SETTING: Four clinical centers, one each located in the following areas: Baltimore, Md; Minneapolis, Minn; Portland, Ore; and the Monongahela Valley in Pennsylvania. PARTICIPANTS: A total of 6854 nonblack women who were 65 years of age or older and enrolled in the Study of Osteoporotic Fractures. MEASUREMENTS: Radius and calcaneus BMD by single photon absorptiometry at baseline; hip and spine BMD by dual-energy x-ray absorptiometry 2 years later. MAIN OUTCOME MEASURE: Breast cancer confirmed by medical record review.
RESULTS: A total of 97 women developed breast cancer. In the multivariate model, adjusting for age, the degree of obesity, and other important covariates, the risk of breast cancer was about 30% to 50% higher per 1 SD increase in BMD (relative risk, distal radius BMD=1.50; 95% confidence interval, 1.16-1.95). The age-adjusted incidence rate of breast cancer per 1000 person-years among women in the lowest quartile of distal radius BMD was 2.46, compared with 5.99 among women with the highest BMD. Women with BMD above the 25th percentile were at 2.0 to 2.5 times increased risk of breast cancer compared with women below the 25th percentile. Results were consistent across all BMD sites.
CONCLUSIONS: Bone mineral density predicts the risk of breast cancer in older women. The magnitude of the association is similar to that observed between BMD and all fractures. Our findings suggest a link between 2 of the most common conditions affecting a woman's health. Identifying a common denominator for these conditions should substantially improve our understanding of their etiology and prevention.

Entities:  

Mesh:

Year:  1996        PMID: 8892715

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  56 in total

1.  Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort.

Authors:  Katherine W Reeves; Vicki McLaughlin; Lisa Fredman; Kristine Ensrud; Jane A Cauley
Journal:  Cancer Causes Control       Date:  2012-06-02       Impact factor: 2.506

2.  Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Authors:  Fredrik Borgström; Olof Johnell; John A Kanis; Anders Oden; David Sykes; Bengt Jönsson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women.

Authors:  T Suzuki; H Yoshida
Journal:  Osteoporos Int       Date:  2009-06-05       Impact factor: 4.507

4.  Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009.

Authors:  C D O'Malley; N Tran; C Zapalowski; N Daizadeh; T P Olenginski; J A Cauley
Journal:  Osteoporos Int       Date:  2014-05-24       Impact factor: 4.507

5.  Epidemiology of osteoporosis in the United States of America.

Authors:  R D Wasnich
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  Elevated incidence of fractures in women with invasive breast cancer.

Authors:  B J Edwards; W J Gradishar; M E Smith; J A Pacheco; J Holbrook; J M McKoy; B Nardone; S Tica; V Godinez-Puig; A W Rademaker; I B Helenowski; A D Bunta; P H Stern; S T Rosen; D P West; T A Guise
Journal:  Osteoporos Int       Date:  2015-08-21       Impact factor: 4.507

7.  Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative.

Authors:  Zhao Chen; Leslie Arendell; Mikel Aickin; Jane Cauley; Cora E Lewis; Rowan Chlebowski
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

8.  Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.

Authors:  Jane Green; Gabriela Czanner; Gillian Reeves; Joanna Watson; Lesley Wise; Valerie Beral
Journal:  BMJ       Date:  2010-09-01

9.  Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women.

Authors:  Mellissa Yong; Charlotte Atkinson; Katherine M Newton; Erin J Aiello Bowles; Frank Z Stanczyk; Kim C Westerlind; Victoria L Holt; Stephen M Schwartz; Wendy M Leisenring; Johanna W Lampe
Journal:  Cancer Causes Control       Date:  2009-03-12       Impact factor: 2.506

10.  Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.

Authors:  P A Newcomb; A Trentham-Dietz; J M Hampton
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.